Page last updated: 2024-08-26

cobalt and 12-o-retinoylphorbol-13-acetate

cobalt has been researched along with 12-o-retinoylphorbol-13-acetate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biswas, S; Kumar, N; Nayak, PG; Rao, CM; Reddy, ND; Shoja, MH1

Other Studies

1 other study(ies) available for cobalt and 12-o-retinoylphorbol-13-acetate

ArticleYear
An appraisal of cinnamyl sulfonamide hydroxamate derivatives (HDAC inhibitors) for anti-cancer, anti-angiogenic and anti-metastatic activities in human cancer cells.
    Chemico-biological interactions, 2016, Jun-25, Volume: 253

    Topics: A549 Cells; Acetylation; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cobalt; Cyclin-Dependent Kinase Inhibitor p21; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Hypoxia-Inducible Factor 1, alpha Subunit; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; MCF-7 Cells; Phorbol Esters; Poly(ADP-ribose) Polymerases; Sulfonamides; Tubulin; Tumor Suppressor Protein p53

2016